These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 36279295

  • 1. Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
    Andrews M, Yoshida T, Henderson CM, Pflaum H, McGregor A, Lieberman JA, de Boer IH, Vaisar T, Himmelfarb J, Kestenbaum B, Chung JY, Hewitt SM, Santo BA, Ginley B, Sarder P, Rosenberg AZ, Murakami T, Kopp JB, Kuklenyik Z, Hoofnagle AN.
    PLoS One; 2022; 17(10):e0276649. PubMed ID: 36279295
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypoxia hits APOL1 in the kidney.
    Grampp S, Krüger R, Lauer V, Uebel S, Knaup KX, Naas J, Höffken V, Weide T, Schiffer M, Naas S, Schödel J.
    Kidney Int; 2023 Jul; 104(1):53-60. PubMed ID: 37098381
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.
    Yang YW, Poudel B, Frederick J, Dhillon P, Shrestha R, Ma Z, Wu J, Okamoto K, Kopp JB, Booten SL, Gattis D, Watt AT, Palmer M, Aghajan M, Susztak K.
    Mol Ther; 2022 Jul 06; 30(7):2491-2504. PubMed ID: 35450819
    [Abstract] [Full Text] [Related]

  • 8. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
    Wen H, Kumar V, Lan X, Shoshtari SSM, Eng JM, Zhou X, Wang F, Wang H, Skorecki K, Xing G, Wu G, Luo H, Malhotra A, Singhal PC.
    Biosci Rep; 2018 Aug 31; 38(4):. PubMed ID: 29967295
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Cell Biology of APOL1.
    O'Toole JF, Bruggeman LA, Madhavan S, Sedor JR.
    Semin Nephrol; 2017 Nov 31; 37(6):538-545. PubMed ID: 29110761
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Apolipoprotein L1 Gene and Cardiovascular Disease.
    Robinson TW, Freedman BI.
    Methodist Debakey Cardiovasc J; 2016 Nov 31; 12(4 Suppl):2-5. PubMed ID: 28298955
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.
    McCarthy GM, Blasio A, Donovan OG, Schaller LB, Bock-Hughes A, Magraner JM, Suh JH, Tattersfield CF, Stillman IE, Shah SS, Zsengeller ZK, Subramanian B, Friedman DJ, Pollak MR.
    Dis Model Mech; 2021 Aug 01; 14(8):. PubMed ID: 34350953
    [Abstract] [Full Text] [Related]

  • 18. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.
    Ekulu PM, Adebayo OC, Decuypere JP, Bellucci L, Elmonem MA, Nkoy AB, Mekahli D, Bussolati B, van den Heuvel LP, Arcolino FO, Levtchenko EN.
    Cells; 2021 Jul 28; 10(8):. PubMed ID: 34440683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
    Ge M, Molina J, Ducasa GM, Mallela SK, Varona Santos J, Mitrofanova A, Kim JJ, Liu X, Sloan A, Mendez AJ, Banerjee S, Liu S, Szeto HH, Shin MK, Hoek M, Kopp JB, Fontanesi F, Merscher S, Fornoni A.
    Hum Mol Genet; 2021 Apr 26; 30(3-4):182-197. PubMed ID: 33517446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.